<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03123367</url>
  </required_header>
  <id_info>
    <org_study_id>CLP-0001</org_study_id>
    <nct_id>NCT03123367</nct_id>
  </id_info>
  <brief_title>Evaluation of the Nella Women's Care Line</brief_title>
  <official_title>An Evaluation of the Safety and TechnIcal Feasibility Of the NelLa Women's Care Line for Female Gynecological ExaminaTions and Procedures (VIOLET)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Ceek Enterprises</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Ceek Enterprises</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_unapproved_device>Yes</is_unapproved_device>
    <is_ppsd>No</is_ppsd>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      Evaluation of the Nella Women's Care Line
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The Nella Women's Care Line is being studied in women undergoing a gynecological exam and
      other gynecological procedures that require visibility and access to the cervix.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">March 6, 2017</start_date>
  <completion_date type="Actual">June 27, 2017</completion_date>
  <primary_completion_date type="Actual">June 27, 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Technical Feasibility</measure>
    <time_frame>Day of Exam or Procedure</time_frame>
    <description>Cervical visualization and access</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Safety</measure>
    <time_frame>Day of Exam or Procedure</time_frame>
    <description>Number of Adverse Events (AEs)</description>
  </secondary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Actual">154</enrollment>
  <condition>GYN Disorders</condition>
  <arm_group>
    <arm_group_label>Group 1: Nella VuSleeve</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Sleeve</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group 2: Nella NuSpec</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Speculum</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group 3: NellaSpec</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Speculum</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group 4: Nella Insert</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Sleeve</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Group 1: Nella VuSleeve</intervention_name>
    <description>Sleeve</description>
    <arm_group_label>Group 1: Nella VuSleeve</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Group 2: Nella NuSpec</intervention_name>
    <description>Speculum</description>
    <arm_group_label>Group 2: Nella NuSpec</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Group 3: NellaSpec</intervention_name>
    <description>Speculum</description>
    <arm_group_label>Group 3: NellaSpec</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Group 4: Nella Insert</intervention_name>
    <description>Sleeve</description>
    <arm_group_label>Group 4: Nella Insert</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        General inclusion criteria (applies to all study groups):

          -  Subject is female

          -  Subject is 18 - 65 years of age, inclusive, at the time of consent

          -  Subject is undergoing a gynecological examination (as defined above) as part of their
             regular clinical care

          -  Subject has undergone one or more prior gynecological exams

          -  Subject is willing and able to provide written informed consent

          -  Subject is able and willing to perform the functions required by the study protocol

        General exclusion criteria (applies to all study groups):

          -  Subject has undergone hysterectomy

          -  Subject has a known history of allergies to latex or plastics

          -  Subject is pregnant

          -  Subject is post-partum (≤ 12 weeks)

          -  Subject has had an induced or spontaneous abortion in the prior 12 weeks

          -  Subject has an active gynecologic complaint that, in the opinion of the clinician,
             would confound study results

          -  Subject has dyspareunia

          -  Subject has a known history of vulvodynia such as vulvular vestibular syndrome

          -  Subject has a known history of vaginismus

          -  Subject has a planned surgical procedure along with the gynecological exam

          -  Subject is under incarceration

          -  Subject is unable to provide written informed consent

        Device specific inclusion criteria:

        In addition to the general inclusion, the subject must meet all device specific criteria
        associated with their assignment group. Below are device-specific criteria. There is no
        device-specific exclusion criterion.

        Nella VuSleeve (Group 1) inclusion:

        • Subject has a BMI ≥ 30 and/or 3 or more vaginal births

        NellaSpec (Group 2), Nella NuSpec (Group 3), and Nella Insert (Group 4) inclusion:

        • Subject has a BMI &lt; 35
      </textblock>
    </criteria>
    <gender>Female</gender>
    <gender_based>Yes</gender_based>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ceek Clinical Research</last_name>
    <role>Study Director</role>
    <affiliation>Ceek Enterprises</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Research Site</name>
      <address>
        <city>Portland</city>
        <state>Oregon</state>
        <zip>97209</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>March 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 5, 2017</study_first_submitted>
  <study_first_submitted_qc>April 20, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">April 21, 2017</study_first_posted>
  <last_update_submitted>March 14, 2018</last_update_submitted>
  <last_update_submitted_qc>March 14, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">March 16, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

